- Home
- WBX vs STRO Comparison
WBX vs STRO Comparison
Compare WBX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- STRO
- Stock Information
- Founded
- WBX 2015
- STRO 2003
- Country
- WBX Spain
- STRO United States
- Employees
- WBX N/A
- STRO N/A
- Industry
- WBX Industrial Specialties
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WBX Consumer Discretionary
- STRO Health Care
- Exchange
- WBX Nasdaq
- STRO Nasdaq
- Market Cap
- WBX 102.7M
- STRO 77.7M
- IPO Year
- WBX N/A
- STRO 2018
- Fundamental
- Price
- WBX $5.65
- STRO $0.76
- Analyst Decision
- WBX Buy
- STRO Hold
- Analyst Count
- WBX 3
- STRO 7
- Target Price
- WBX $0.72
- STRO $3.97
- AVG Volume (30 Days)
- WBX 496.2K
- STRO 1.4M
- Earning Date
- WBX 07-31-2025
- STRO 08-12-2025
- Dividend Yield
- WBX N/A
- STRO N/A
- EPS Growth
- WBX N/A
- STRO N/A
- EPS
- WBX N/A
- STRO N/A
- Revenue
- WBX $171,352,140.00
- STRO $66,434,000.00
- Revenue This Year
- WBX N/A
- STRO N/A
- Revenue Next Year
- WBX $44.10
- STRO N/A
- P/E Ratio
- WBX N/A
- STRO N/A
- Revenue Growth
- WBX 3.75
- STRO N/A
- 52 Week Low
- WBX $0.23
- STRO $0.52
- 52 Week High
- WBX $5.99
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- WBX 34.74
- STRO 44.92
- Support Level
- WBX $5.80
- STRO $0.67
- Resistance Level
- WBX $6.36
- STRO $0.79
- Average True Range (ATR)
- WBX 0.64
- STRO 0.07
- MACD
- WBX -0.06
- STRO -0.01
- Stochastic Oscillator
- WBX 38.62
- STRO 34.52
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.